INSIGHTS ON PHARMA LOGISTICS

• Chronicle Software: Scaling For Needs In Cell Therapy

  Get support for your team through visibility of process data, locally and across your manufacturing sites. Obtain greater oversight of day-to-day operations, receive text and email-alerts of equipment alarms, and produce electronic batch records.

• Validation Of Integrated Cryogenic Systems For Point Of Care Cellular Manufacturing

  Amittha Wickrema, Ph.D., Professor of Medicine, Director, Advanced Cellular Therapeutics Facility, University of Chicago, reviews the cold chain workflow from start to finish for a cellular therapy product.

• Internal Logistics: Exploring The Last 100m

  If advanced therapies are to be scaled, their management at hospital sites has to be scalable. How can we take complexity out — making life easier for couriers, manufacturers and hospitals — and create a seamless supply chain?

• Achieving A Flexible, Integrated And Sustainable Cryogenic Cold Chain Ecosystem

  During this discussion, panelists examine the cell and gene therapy solutions that have been designed to overcome challenges in the cryogenic cold chain ecosystem.

• Digitally Connected, Liquid Nitrogen-Free Cryogenic Cold Chain

  4/12/2021

  A cryogenic cold chain starts with cryopreservation. Achieve consistent results without liquid nitrogen, scale effectively and efficiently, and get traceable digital records.

• Switch To A Nitrogen-Free Cryopreservation System

  4/5/2021

  This study focuses on the running costs and carbon emissions associated with cryopreservation equipment, comparing a liquid nitrogen (LN₂)-free controlled-rate freezer with a typical liquid nitrogen-based system. The environmental implications of using liquid nitrogen for cell freezing are explored along with carbon emissions during the manufacture, transportation, and operation of LN₂-free controlled-rate freezers.

• The Science Of Cell Therapy Thawing

  4/5/2021

  This guide summarizes the science of thawing following conventional, slow freezing methods. We address how cell thawing has historically developed into the techniques used today, along with the physical and biological implications of key metrics and components, such as warming rate and ice structure. Also included are reviews of key studies from scientific literature and a consideration of the interactions between cooling and warming rates, as applicable to cell and gene therapies.

• Need For Speed: The Key To Successful Multi-Market Product Launches

  3/29/2021

  Launching a new drug in the European marketplace presents unique challenges. Numerous official working languages, complex independent regulatory requirements with an overarching framework, and the intricacy and scale of distribution are all characteristics of an EU launch. Jumping these hurdles is a given, but it’s the speed that makes the difference.